Sympathetic activation in obesity

Information

  • Research Project
  • 10412286
  • ApplicationId
    10412286
  • Core Project Number
    R56DK129344
  • Full Project Number
    1R56DK129344-01
  • Serial Number
    129344
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/12/2021 - 3 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    LAUGHLIN, MAREN R
  • Budget Start Date
    9/12/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/12/2021 - 3 years ago
Organizations

Sympathetic activation in obesity

Project Summary Obesity is associated with an increased risk of diabetes and cardiovascular disease. Sympathetic nervous system (SNS) dysfunction has been described in individuals with obesity and may be implicated in the pathogenesis of obesity-related comorbidities. SNS regulates energy homeostasis by promoting a coordinated multi-organ response. Regionalized SNS hyperactivation of certain organs (fat, skeletal muscle and kidneys) but not others (adrenal glands, heart) has been observed in individuals with obesity. Dysfunctional coordination of SNS activation to target organs may explain the increased risk of cardiometabolic disorders in obesity. SNS activates target-organs by releasing norepinephrine (NE) which is then recycled back by pre-synaptic norepinephrine transporters (NET). Whole-body positron emission tomography (PET) with the radiotracer for norepinephrine transporters ((S,S)-11C-O- methylreboxetine ([11C]MRB) has been used to quantify NET availability in vivo in humans and rodents in: a) peripheral tissues (brown and white adipose tissues and skeletal muscle); and b) in the central nervous system. Studies using [11C]MRB PET imaging showed that NET-availability in brown adipose tissue (BAT) was reduced in women with obesity. In addition, [11C]MRB binding in skeletal muscle (deltoid) inversely correlated with body mass index (BMI) in healthy women. Therefore, to determine whether regionalized SNS activation of target organs is altered by obesity, healthy men and women with normal body mass index (BMI) and with obesity will undergo whole body [11C]MRB PET imaging and microneurography (gold standard test for assessment of muscle SNS activity). To further investigate the impact of obesity in coordinating SNS multi-organ activation, SNS activity will be also measured in response to a food challenge. Parallel animal studies will be performed to clarify the relationship between peripheral and central NET dynamics and the time course of which each of these NET sources change as obesity develops. Whole body [11C]MRB PET imaging allows simultaneous multi-organ measurements and this project will help further understand the impact of obesity in SNS activity. Dysregulated coordination of SNS activity may play a role in the pathophysiology of obesity-related cardiometabolic disorders.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R56
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    101250
  • Total Cost
    251250
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDDK:251250\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    HSDO
  • Study Section Name
    Human Studies of Diabetes and Obesity Study Section
  • Organization Name
    YALE UNIVERSITY
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    043207562
  • Organization City
    NEW HAVEN
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    065208327
  • Organization District
    UNITED STATES